Bolt Biotherapeutics logo

Bolt Biotherapeutics Share Price Today

(NASDAQ: BOLT)

Bolt Biotherapeutics share price is $0.45 & ₹39.18 as on 6 Mar 2025, 2.30 'hrs' IST

$0.45

Market is closed - opens 8 PM, 06 Mar 2025

View live Bolt Biotherapeutics share price in Dollar and Rupees. Guide to invest in Bolt Biotherapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Bolt Biotherapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Bolt Biotherapeutics share price movements

  • Today's Low: $0.44
    Today's High: $0.47

    Day's Volatility :6.36%

  • 52 Weeks Low: $0.42
    52 Weeks High: $1.56

    52 Weeks Volatility :73.01%

Bolt Biotherapeutics (BOLT) Returns

PeriodBolt Biotherapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
-20.96%
3.7%
0.0%
6 Months
-31.54%
-2.8%
0.0%
1 Year
-64.4%
2.5%
0.0%
3 Years
-85.41%
12.9%
-11.6%

Bolt Biotherapeutics (BOLT) Key Statistics

in dollars & INR

Previous Close
$0.4422
Open
$0.4699
Today's High
$0.4699
Today's Low
$0.44
Market Capitalization
$16.9M
Today's Volume
$14.7K
52 Week High
$1.56
52 Week Low
$0.4211
Revenue TTM
$9.8M
EBITDA
$-70.5M
Earnings Per Share (EPS)
$-1.71
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-64.99%

How to invest in Bolt Biotherapeutics Stock (BOLT) from India?

It is very easy for Indian residents to invest directly in Bolt Biotherapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Bolt Biotherapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Bolt Biotherapeutics or BOLT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Bolt Biotherapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Bolt Biotherapeutics shares which would translate to 1.935 fractional shares of Bolt Biotherapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Bolt Biotherapeutics, in just a few clicks!

Returns in Bolt Biotherapeutics (BOLT) for Indian investors in Rupees

The Bolt Biotherapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Bolt Biotherapeutics investment value today

Current value as on today

₹41,065

Returns

₹58,935

(-58.94%)

Returns from Bolt Biotherapeutics Stock

₹64,000 (-64%)

Dollar Returns

₹5,065 (+5.06%)

Indian investors sentiment towards Bolt Biotherapeutics (BOLT)

-22%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Bolt Biotherapeutics Stock from India on INDmoney has decreased by -22% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Bolt Biotherapeutics

  • TANG CAPITAL MANAGEMENT LLC

    9.96%

  • Vivo Capital, LLC

    9.20%

  • Sofinnova Ventures

    7.20%

  • Pivotal bioVenture Partners Investment Advisor LLC

    4.94%

  • Vanguard Group Inc

    2.79%

  • Samsara BioCapital, LLC

    2.74%

Analyst Recommendation on Bolt Biotherapeutics

Buy

    83%Buy

    16%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Bolt Biotherapeutics(by analysts ranked 0 to 5 stars)

Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
10
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Bolt Biotherapeutics Stock (BOLT)

What analysts predicted

Upside of 288.89%

Target:

$1.75

Current:

$0.45

Insights on Bolt Biotherapeutics Stock (Ticker Symbol: BOLT)

  • Price Movement

    In the last 7 days, BOLT stock has moved down by -7.1%
  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 5.27M → 1.14M (in $), with an average decrease of 43.2% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -21.19M → -15.17M (in $), with an average increase of 39.7% per quarter
  • BOLT vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 130.9%
  • BOLT vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 136.4%
  • Price to Sales

    ForBOLT every $1 of sales, investors are willing to pay $1.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Bolt Biotherapeutics Technicals Summary

Sell

Neutral

Buy

Bolt Biotherapeutics is currently in a neutral trading position according to technical analysis indicators.

Bolt Biotherapeutics (BOLT) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Bolt Biotherapeutics Inc logo
-5.32%
-31.54%
-64.4%
-85.41%
-98.62%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Bolt Biotherapeutics Inc logo
NA
NA
NA
-1.5
-0.65
-0.32
NA
1.88
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Bolt Biotherapeutics Inc logo
Buy
$16.9M
-98.62%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Bolt Biotherapeutics

Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company's lead product candidate BDC-1001, which is in clinical development for the treatment of patients with human epidermal growth factor receptor 2- positive solid tumors, including breast, colorectal, endometrial, and gastroesophageal cancer. It is also developing BDC-3042, an agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer. The company has collaboration agreements with Toray Industries, Genmab A/S, Innovent Biologics, Inc., Bristol-Myers Squibb, and F. Hoffmann-La Roche Ltd; and license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City, California.
Organization
Bolt Biotherapeutics
Employees
100
CEO
Mr. William P. Quinn
Industry
Healthcare

Management People of Bolt Biotherapeutics

NameTitle
Mr. William P. Quinn
CEO, CFO, President, Secretary & Director
Mr. Grant Yonehiro C.F.A., M.B.A.
Chief Operating Officer
Ms. Sarah Nemec
VP of Finance & Principal Accounting Officer
Mr. Wesley Burwell
VP & Head of Human Resources
Dr. Nathan Ihle Ph.D.
Senior Vice President of Pharmaceutical Operations
Dr. Michael N. Alonso Ph.D.
Senior Vice President of Research

Important FAQs about investing in BOLT Stock from India :

What is Bolt Biotherapeutics share price today?

Bolt Biotherapeutics share price today stands at $0.45, Open: $0.47 ; Previous Close: $0.44 ; High: $0.47 ; Low: $0.44 ; 52 Week High: $1.56 ; 52 Week Low: $0.42.

The stock opens at $0.47, after a previous close of $0.44. The stock reached a daily high of $0.47 and a low of $0.44, with a 52-week high of $1.56 and a 52-week low of $0.42.

Can Indians buy Bolt Biotherapeutics shares?

Yes, Indians can invest in the Bolt Biotherapeutics (BOLT) from India.

With INDmoney, you can buy Bolt Biotherapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Bolt Biotherapeutics at zero transaction cost.

How can I buy Bolt Biotherapeutics shares from India?

It is very easy to buy Bolt Biotherapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Bolt Biotherapeutics (BOLT) be purchased?

Yes, you can buy fractional shares of Bolt Biotherapeutics with INDmoney app.

What are the documents required to start investing in Bolt Biotherapeutics stocks?

To start investing in Bolt Biotherapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Bolt Biotherapeutics Stock (BOLT)?

Today’s highest price of Bolt Biotherapeutics (BOLT) is $0.47.

Today’s lowest price of Bolt Biotherapeutics (BOLT) is $0.44.

What is today's market capitalisation of Bolt Biotherapeutics?

Today's market capitalisation of Bolt Biotherapeutics BOLT is 16.9M

What is the 52 Week High and Low Range of Bolt Biotherapeutics Stock (BOLT)?

  • 52 Week High

    $1.56

  • 52 Week Low

    $0.42

What are the historical returns of Bolt Biotherapeutics (BOLT)?

  • 1 Month Returns

    -5.32%

  • 3 Months Returns

    -31.54%

  • 1 Year Returns

    -64.4%

  • 5 Years Returns

    -98.62%

Who is the Chief Executive Officer (CEO) of Bolt Biotherapeutics ?

Mr. William P. Quinn is the current Chief Executive Officer (CEO) of Bolt Biotherapeutics.